Apple Inc. (AAPL) was reiterated an ‘Outperform’ by RBC Capital Markets analysts on Thursday. The broker also cut its price target on the stock to $130 from $140 saying they are lowering March-quarter iPhone units to 45 million units from 54 million to reflect incremental softness and recent production cuts. Nektar Therapeutics (NKTR) was reiterated […]
View the full post at: Notable Upgrades: Apple (AAPL), Nektar Therapeutics (NKTR), Science Applications (SAIC), Nordson (NDSN)